PharmaBoardroom

Drones are Taking Off in Healthcare

Brendan Shaw takes a look at the rise of drone technology in medical product delivery and its implications for the future of healthcare.…

Speeding up the Search for Safe & Effective COVID-19…

IFPMA Director General Thomas B. Cueni shares the outcomes of a recent high level pharma industry media briefing on the search for a COVID-19…

Standing on the Shoulders of Giants: The Art & Science of…

DataArt's Daniel Piekarz looks at how machine learning and artificial intelligence can play into the important task of drug repurposing, potentially…

Worried About Biogen’s Aducanumab? Don’t Be

Dr Neil Cashman examines the recent news around Biogen's Alzheimer's treatment aducanumab, assuages some investor fears, and underlines the…

Forging Connections & Trust – At A Safe Social…

Takeda’s Head of R&D Patient Engagement Jessica Scott examines the parallels between partnering with patients and working remotely with…

Cell & Gene Therapy Manufacturing: Critical Challenges,…

Deloitte's Omkar Kawalekar, Hussain Mooraj, and Amit Agarwal examine the evolution and future of cell and gene therapy manufacturing and the areas in…

Why Technology Is Key To Surviving COVID-19

Sophia Ononye-Onyia outlines the key failings in the USA’s response to the coronavirus outbreak and why greater numbers of inter-industry…

China’s Regulatory Reform and its Contribution to Global…

Song Ruilin, chairman of the China Pharmaceutical Innovation and Research Development Association (PhIRDA) highlights the leaps and bounds with which…

“Drug” Companies are Missing Their Moment to Write a New…

John G. Singer examines how the ongoing coronavirus pandemic may create a new dichotomy for global healthcare - and why pharma companies still wedded…